HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation

Area of Science:

• Molecular Biology
• Cancer Research
• Drug Discovery

Background:

• Hypoxia-inducible factor 1-alpha (HIF-1α) is a key transcription factor in cancer, but its modulation is challenging.
• The 'undruggable' nature of transcription factors limits conventional therapeutic strategies.
• Decoy approaches offer a novel antigene strategy to target transcriptional factors.

Purpose of the Study:

• To design and evaluate the efficacy of a decoy oligodeoxynucleotide (ODN) targeting HIF-1α.
• To assess the impact of HIF-1α decoy ODNs on cancer cell function and viability.
• To explore the potential of HIF-1α decoy ODNs as a therapeutic strategy for cancer.

Main Methods:

• Design and synthesis of a specific HIF-1α decoy oligodeoxynucleotide (ODN).
• In vitro assessment of ODN cellular uptake and intracellular activity.
• Quantification of VEGFA expression, a known HIF-1α target gene.
• Evaluation of apoptosis induction and cell cycle arrest in MDA-MB-231 breast cancer cells.

Main Results:

• HIF-1α decoy ODNs demonstrated efficient cellular entry.
• Decoy ODNs significantly inhibited VEGFA expression, indicating HIF-1α functional blockade.
• Treatment with HIF-1α decoy ODNs induced apoptosis and cell cycle arrest in breast cancer cells.
• The study confirmed the inhibitory effect of HIF-1α decoy ODNs on HIF-1α activity.

Conclusions:

• HIF-1α decoy ODNs effectively inhibit HIF-1α transcriptional activity.
• Decoy ODNs represent a viable strategy for inducing cancer cell apoptosis and cell cycle arrest.
• Further optimization of HIF-1α decoy ODNs is warranted to enhance in vivo biological activity for potential therapeutic applications.